CD8A and neoplasm: This strategy suppresses neovascularization, reduces hypoxia-induced IGF-II secretion, enhances CD8+ T-cell infiltration, and creates a dual vascular-immune inhibition of the tumor microenvironment, thereby reversing tumor growth.